Treat patents as strategic business assets and build an IP portfolio.
Adam Schoen, JD
Advertisement
Articles by Adam Schoen, JD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
3
Pharmaceutical Executive Daily: FDA Approves Breztri
4
How are US Regulatory Actions Impacting Pricing?
5